Vernalis to raise £68.5m 10/02/2012
Drug discoverer Vernalis (VER) is to raise £68.5 million as part of a joint venture with US concern Tris Pharma.
Contract research concern Cyprotex is to buy Boston-based counterpart Apredica in a £2.68 million shares and cash deal.
Macclesfield-based Cyprotex, which specialises in pre-clinical absorption, distribution, metabolism and excretion (ADME) assessments of drug candidates, has agreed to issue 44.7 million shares and to pay £1 million cash for Apredica, a specialist in ADME and toxicology assessment.
Apredica brings with it intellectual property and other assets lately acquired from fellow US concern Cellumen relating to cellular systems biology and high content toxicology services previously offered by that company. The deal, which brings together two market leaders in 'ADME Tox' (ADMET), will see Apredica's two co-founders, Dr. Katya Tsaioun and Douglas Bates, join the enlarged group as chief scientific officer and chief marketing officer respectively, under Cyprotex's chief executive officer Dr. Anthony Baxter.
Floated on AIM eight years ago at 29p, Cyprotex shares have been dire performers until recently, falling at one point to a mere 2p. They have lately shown signs of life, rising form 3.63p, where Growth Company Investor highlighted them in March, to 4p now, valuing the company at £7.2 million.
Hold on.
Subscribe today and save 50%. Receive company watch recommendations and extensive company profile tips, released two months ahead of the market.
Advertisement
£100 credit when you open five trades within 60 days – terms apply. Spread Trading is not for everyone please ensure you understand the risks as you may lose more than your initial deposit. Click here for more information.
This unique study analyses the shareholdings of companies listed on AIM, extracting trends including rankings of the value and number of their investments.
Please click here to order your copy of the report or call 0207 250 7056.
Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.
If you're interested in business tax updates visit our specialist tax guide website.
Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.
Advertisement
Drug discoverer Vernalis (VER) is to raise £68.5 million as part of a joint venture with US concern Tris Pharma.
Magnolia Petroleum (MAGP) has acquired 800 acres in the Mississippi Lime formation in Oklahoma.
Gold explorer Condor Resources (CNR) has reported encouraging results from drilling at its La India project in Nicaragua.
US-focused Nighthawk Energy is launching a $7.5 million program to invest in its Colorado-based Jolly Ranch project.
Africa-focused Tower Resources (TRP) has raised £5.4 million via a placing with a mixture of institutional investors and directors.
Beleaguered travel operator Thomas Cook (TCG) has reported a loss of £91 million its first quarter also announcing the sale of its Indian division.